Skip to main content
. 2021 May 26;12:636202. doi: 10.3389/fneur.2021.636202

Table 1.

Demographic and clinical characteristics of the participants.

Characteristics HCs (n = 14) EwoM (n = 16) EwM (n = 16) P
Gender (M/F) 7/7 7/9 6/10 0.774*
Age, years, mean (SD) 25.6 (4.6) 28.8 (5.9) 25.3 (6.3) 0.169
Education, years, mean (SD) 12.6 (3.8) 14.0 (4.0) 11.9 (3.4) 0.276
MMSE, scores, mean (SD) 29.4 (0.9) 29.0 (1.8) 28.3 (1.9) 0.178
HDRS, scores, mean (SD) 1.4 (0.9) 2.5 (1.3) 7.6 (3.7) <0.001
Epilepsy duration, month, mean (SD) - 81.3 (53.7) 75.3 (57.8) 0.766
Mean seizure frequency, times/year, mean (SD) 2.3 (1.8) 4.8 (2.7) 0.005
Mean migraine frequency, days/month, mean (SD) - 1.5 (0.5)
Form of migraine
IIM (patients number) 7
PIM - 12
MwA - 1
MwoA - 15
VAS, scores, mean (SD) - 4.5 (1.4)
Medications
Monotherapy (patients number) 12 6 0.033*
Drug combination 4 10

SD, standard deviation; HCs, healthy controls; EwoM, epilepsy without migraine; EwM, epilepsy with comorbid migraine; MMSE, Mini-mental State Examination; HDRS, Hamilton depression rating scale; IIM, inter-ictal migraine; PIM, post ictal migraine; MwA, migraine with aura; MwoA, migraine without aura; VAS, visual analog scale/score; n, number. Medications presents antiepileptic drugs.

*

chi-square fisher exact test.